Trudel new chief executive at Encision

BOULDER – Medical-device company Encision Inc. has selected Greg Trudel as its president and chief executive, replacing Fred Perner, who died of a heart attack in August.

Trudel will start working at Encision (ECIA: PK) on Monday, Dec. 23, according to the company. Encision makes and sells surgical devices used in minimally invasive surgery.

Patrick W. Pace, executive chairman of the company, said Trudel brings a legacy of success and fresh energy to Encision.

SPONSORED CONTENT

Commercial Solar is a big investment, but not an overwhelming one

Solar offers a significant economic benefit for commercial property owners while also positively impacting the environment and offering a path to compliance for new municipal requirements like Energize Denver. A local, experienced solar installer will help you navigate the complexities of commercial solar to achieve financial success for your project.

Trudel previously was the global director of marketing for Covidien Plc. Prior to that he held leadership roles with ConMed Corp.’s electrosurgery division, SilverGlide Surgical Technologies Inc. and Stryker Corp.

Encision said Wednesday that it raised $2 million through a private placement of 2.5 million shares of its common stock.

The private placement represents 23 percent of the total number of shares in the company. The purchase price per share was 80 cents. Proceeds will be used for general corporate purposes, the company said in a statement.